Medivation Inc (MDVN)

81.44
0.02 0.02
NASDAQ : Health Care
Prev Close 81.42
Open 81.44
Day Low/High 81.43 / 81.48
52 Wk Low/High 26.41 / 63.34
Volume 7.20M
Avg Volume 4.26M
Exchange NASDAQ
Shares Outstanding 165.93M
Market Cap 13.51B
EPS 1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Medivation Reiterates Rejection Of Sanofi's Substantially Inadequate Proposal

Medivation Reiterates Rejection Of Sanofi's Substantially Inadequate Proposal

Medivation, Inc. (NASDAQ:MDVN) today reiterated its rejection of Sanofi's substantially inadequate proposal to acquire the Company for $52.

Sanofi Threatens to go Hostile in Medivation Battle

Sanofi Threatens to go Hostile in Medivation Battle

France's Sanofi said it would move to oust the current board of Medivation if the latter does not engage in discussions about a transaction.

Interest Rises in Medivation Oncology Prospects

Interest Rises in Medivation Oncology Prospects

Shareholders have written consent to hold the target's board to task.

Cramer: Where'd All the Growth Go?

Checking the gauges for underperformance, none of them look good.

Will a Third Medivation Suitor Present Itself?

Will a Third Medivation Suitor Present Itself?

Pfizer reportedly made a bid for the cancer drug maker, rivaling Sanofi's $9.3 billion offer, but analysts say another company might be the best fit.

Today's Stocks Driving Success For The Health Care Sector

Today's Stocks Driving Success For The Health Care Sector

TheStreet highlights 3 stocks pushing the health care sector higher today.

Medivation (MDVN) Stock Climbs on Potential Pfizer Deal

Medivation (MDVN) Stock Climbs on Potential Pfizer Deal

Medivation (MDVN) stock is higher in early-afternoon trading on Wednesday, as Pfizer (PFE) reportedly considers a takeover bid.

Medivation (MDVN) Highlighted As Momo Momentum Stock

Medivation (MDVN) Highlighted As Momo Momentum Stock

Trade-Ideas LLC identified Medivation (MDVN) as a momo momentum candidate

Pfizer Reportedly Approaches Drugmaker Medivation About a Buyout

Pfizer Reportedly Approaches Drugmaker Medivation About a Buyout

Pfizer (PFE) has reportedly approached San Francisco based cancer drug maker Medivation (MDVN) about a buyout.

May 4 Premarket Briefing: 10 Things You Should Know

May 4 Premarket Briefing: 10 Things You Should Know

U.S. stock futures point lower on Wednesday, European shares trade mixed and Asian stocks finish with losses on global growth concerns.

Week in Review: Apple Becomes a Drag on Wall Street

Week in Review: Apple Becomes a Drag on Wall Street

The markets closed out the month of April with weekly losses and Apple was to blame.

Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation

Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation

The San Francisco target rejects the $9.3 billion offer, but biotech growth and a healthy pipeline mean Sanofi isn't desperate for Medivation's cancer treatments.

European Stocks Fall; British Airways Owner Crashes on Brussels Impact

European Stocks Fall; British Airways Owner Crashes on Brussels Impact

Benchmark indices slip after better-than-forecast data on first-quarter GDP but disappointing news on Eurozone consumer prices.

Jim Cramer's 'Mad Money' Recap: Ignore Icahn, Think for Yourself

Jim Cramer's 'Mad Money' Recap: Ignore Icahn, Think for Yourself

Apple might be down but other tech stocks, including Amazon and Facebook, are doing terrific, Cramer says.

Stocks Slip as Slower U.S. Growth Overshadows Facebook Earnings

Stocks Slip as Slower U.S. Growth Overshadows Facebook Earnings

Stocks remain lower by mid-afternoon Thursday as worries over the U.S. economy overshadow better-than-expected earnings from industry giants.

$40 Billion Takeover Has Big Pharma Giddy

$40 Billion Takeover Has Big Pharma Giddy

Thursday's parade of deals seem to answer a question that's been bugging health care investors for most of 2016: why haven't retreating biotech valuations sparked an uptick in M&A activity?

Nasdaq Leads Stocks Higher After Facebook Earnings Win

Nasdaq Leads Stocks Higher After Facebook Earnings Win

The tech-heavy Nasdaq drags broader markets into the green on Thursday morning after a strong earnings win from social network Facebook.

Medivation (MDVN) Stock Surges on Sanofi Bid

Medivation (MDVN) Stock Surges on Sanofi Bid

Medivation (MDVN) stock is rising in mid-morning trading on Thursday after receiving a takeover offer from Sanofi.

Stock Futures Hold Losses as U.S. Growth Slows

Stock Futures Hold Losses as U.S. Growth Slows

Stock futures set up for losses on Thursday after U.S. growth slows to its worst level in two years.

Medivation (MDVN) Off To A Strong Start In Pre-Market Activity

Medivation (MDVN) Off To A Strong Start In Pre-Market Activity

Trade-Ideas LLC identified Medivation (MDVN) as a pre-market leader candidate

Sanofi Presses Medivation to Hold Talks After $9.3B Offer

Sanofi Presses Medivation to Hold Talks After $9.3B Offer

The French pharmaceuticals company takes its campaign to snare the oncology specialist public.

April 28 Premarket Briefing: 10 Things You Should Know

April 28 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are tumbling Thursday and European shares fall sharply after Japan's central bank disappoints investors by standing firm on rates.

European Markets Fall After Bank of Japan Rate Disappointment

European Markets Fall After Bank of Japan Rate Disappointment

Deutsche Bank jumps on brighter-than-expected first-quarter numbers but the prospect of order delays grounds shares in Airbus.

4 Biotech Stocks You Should Be Watching Right Now

4 Biotech Stocks You Should Be Watching Right Now

Biotech stocks are dominating the strong stock charts on our radar.

Analysts' Actions -- Boeing, Hershey, Spirit, Regeneron and More

Analysts' Actions -- Boeing, Hershey, Spirit, Regeneron and More

Here are Wednesday's top research calls, including downgrades for Boeing, Hershey, Spirit Airlines and Regeneron.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARE, ARII, CE, COWN, CPAC, CRCM, ESCA, FORR, HASI, HWKN, MDVN, PAAS, PMBC, PNNT, SPAR Downgrades: LSXMA, LSXMB, LSXMK, MY Initiations: ICBK, LENS Read on to get TheStreet Quant Ratings' detailed report:

Analysts' Actions -- CarMax, Illumina, Pulte, Panera and More

Analysts' Actions -- CarMax, Illumina, Pulte, Panera and More

Here are Tuesday's top research calls, including a pair of downgrades for Illumina, and upgrades for CarMax, PulteGroup and Panera Bread.

Medivation (MDVN) Stock Surges on Takeover Speculation

Medivation (MDVN) Stock Surges on Takeover Speculation

Medivation (MDVN) stock is soaring this morning as AstraZeneca (AZN) reportedly considers making a takeover offer.

European Stocks Fall as Oil Plunges on Doha deadlock  

European Stocks Fall as Oil Plunges on Doha deadlock  

A 5%-plus fall in oil prices drags down global stock benchmarks as well as BP, Shell, Total and other producers.

3 Biotech Stocks With Charts to Watch -- And One Bonus Stock!

3 Biotech Stocks With Charts to Watch -- And One Bonus Stock!

Three biotechs are among our four stocks showing strong technical momentum today.